Skip to main content
Premier Anti-Aging Co.,Ltd. logo

Premier Anti-Aging Co.,Ltd. — Investor Relations & Filings

Ticker · 4934 ISIN · JP3833690005 T Manufacturing
Open in API
Filings indexed 49 across all filing types
Latest filing 2026-03-12 Regulatory Filings
Country JP Japan
Listing T 4934

About Premier Anti-Aging Co.,Ltd.

https://www.p-antiaging.co.jp/en.html

Premier Anti-Aging Co., Ltd. is a company specializing in the anti-aging sector. It engages in the planning, development, import, export, and sales of cosmetics and health foods. The company's portfolio includes multiple brands offering a range of products in skincare, hair care, and inner care. Distribution is managed through various channels, including mail order, wholesale, and retail.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the contents of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 2026
2026-03-12 Japanese
半期報告書－第17期(2025/08/01－2026/01/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Premier Anti-Aging Co., Ltd. in Japan. It contains comprehensive financial statements, management analysis (MDA), and corporate information for the interim period (August 1, 2025, to January 31, 2026). This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan, which corresponds to the 'Interim / Quarterly Report' category in the provided schema. H1 2026
2026-03-12 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type, as they do not contain the actual financial statements themselves. FY 2025
2025-10-24 Japanese
有価証券報告書－第16期(2024/08/01－2025/07/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of a 10-K filing. It contains the official financial statements, business overview, and management indicators for the fiscal year ending July 31, 2025. The document structure, including the cover page (Hyoushi) and the section on management indicators (Keiei Shihyou), confirms it is a comprehensive annual financial report. FY 2025
2025-10-24 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document text contains Japanese regulatory headers, specifically mentioning "第２四半期報告書" (Second Quarter Report) and referencing the Financial Instruments and Exchange Act ("金融商品取引法"). It includes confirmation statements by the CEO and CFO regarding the appropriateness of the filing for the period covering August 1, 2024, to January 31, 2025. A comprehensive report for a period shorter than a year (half-year/quarterly) is classified as an Interim/Quarterly Report (IR). Although it confirms the report's contents, the structure strongly suggests this is the filing itself, not just an announcement of publication, making IR the most appropriate classification over RPA.
2025-03-13 Japanese
半期報告書－第16期(2024/08/01－2025/07/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '第２四半期報告書' (Quarterly Report) for Premier Anti-Aging Co., Ltd., covering the period from August 1, 2024, to January 31, 2025. It contains detailed financial statements, management analysis (MDA), and corporate information as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-03-13 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.